Dayton CCOP
3123 Research Boulevard Suite 150
Dayton, Ohio 45420
(937) 775-1350 http://www.med.wright.edu/dcop/ sid.pinkus@wright.edu

Use our guide to learn which trials are right for you!

We are a regional non-profit cancer research consortium serving the Miami Valley area as well as Cincinnati, Findlay, Greenville, Middletown, Troy, Wilmington and Xenia, Ohio and Richmond and Indianapolis, Indiana. Dayton Clinical Oncology Program, in cooperation with our participating area hospitals and universities and physicians, is a National Cancer Institute designated Community Clinical Oncology Program (CCOP).

Our mission is to reduce cancer incidence and mortality through improved treatment and prevention by offering national state-of-the-art cancer research to the local communities. We maintain an active list of approximately 100 clinical trials for the treatment of cancers of the brain, breast, gastrointestinal, genitorinary, head and neck, leukemia, lung, lymphoma, melanoma, myeloma, sarcoma, and other sites, and for cancer prevention and cancer control.

We've found
4 trials
at this facility
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
mi
from
Dayton, OH
Click here to add this to my saved trials
Neurology, Oncology, Psychiatry / Psychology Clinical Trial
Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 11/9/2012
mi
from
Dayton, OH
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/30/2011
mi
from
Dayton, OH
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Dayton, OH
Click here to add this to my saved trials